fbpx

Science

Study Title
Implication of non-alcoholic fatty liver diseases (NAFLD) in patients with COVID-19: a preliminary analysis
Publication
Journal of Hepatology
Author(s)

Dong Ji, Enqiang Qin, Jing Xu, Dawei Zhang, Gregory Cheng, Yudong Wang, George Lau

Abstract

Liver injury had been observed in COVID-19 patients with incidence ranging from 14–53%. We examined the liver injury patterns and implication of non-alcoholic fatty liver diseases (NAFLD) on clinical outcomes in Chinese with COVID-19.

Date
March 27, 2020
View study

Share This

Related Topics

Coronavirus

Dr. Perlmutter is one of the leading lights in medicine today, illuminating the path for solving chronic illness

Mark Hyman, MD